335 related articles for article (PubMed ID: 26543389)
21. Synthetic Cannabinoids: A Pharmacological and Toxicological Overview.
Roque-Bravo R; Silva RS; Malheiro RF; Carmo H; Carvalho F; da Silva DD; Silva JP
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():187-209. PubMed ID: 35914767
[TBL] [Abstract][Full Text] [Related]
22. Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors.
Noble C; Cannaert A; Linnet K; Stove CP
Drug Test Anal; 2019 Mar; 11(3):501-511. PubMed ID: 30280499
[TBL] [Abstract][Full Text] [Related]
23. Synthetic cannabinoids: the hidden side of Spice drugs.
Pintori N; Loi B; Mereu M
Behav Pharmacol; 2017 Sep; 28(6):409-419. PubMed ID: 28692429
[TBL] [Abstract][Full Text] [Related]
24. Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature.
Armenian P; Darracq M; Gevorkyan J; Clark S; Kaye B; Brandehoff NP
Neuropharmacology; 2018 May; 134(Pt A):82-91. PubMed ID: 29037744
[TBL] [Abstract][Full Text] [Related]
25. [Spice in France: mixed herbs containing synthetic cannabinoids].
Schlatter J; Chiadmi F; Chariot P
Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
[TBL] [Abstract][Full Text] [Related]
26. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
[TBL] [Abstract][Full Text] [Related]
27. Psychosis and synthetic cannabinoids.
Deng H; Verrico CD; Kosten TR; Nielsen DA
Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871
[TBL] [Abstract][Full Text] [Related]
28. Synthetic cannabinoid receptor agonists: classification and nomenclature.
Potts AJ; Cano C; Thomas SHL; Hill SL
Clin Toxicol (Phila); 2020 Feb; 58(2):82-98. PubMed ID: 31524007
[No Abstract] [Full Text] [Related]
29. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.
Ibáñez M; Bijlsma L; van Nuijs AL; Sancho JV; Haro G; Covaci A; Hernández F
J Mass Spectrom; 2013 Jun; 48(6):685-94. PubMed ID: 23722959
[TBL] [Abstract][Full Text] [Related]
30. "Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans.
Gunderson EW; Haughey HM; Ait-Daoud N; Joshi AS; Hart CL
Am J Addict; 2012; 21(4):320-6. PubMed ID: 22691010
[TBL] [Abstract][Full Text] [Related]
31. Emerging drugs of abuse.
Nelson ME; Bryant SM; Aks SE
Emerg Med Clin North Am; 2014 Feb; 32(1):1-28. PubMed ID: 24275167
[TBL] [Abstract][Full Text] [Related]
32. Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis.
Fattore L
Biol Psychiatry; 2016 Apr; 79(7):539-48. PubMed ID: 26970364
[TBL] [Abstract][Full Text] [Related]
33. [Cathinones use in Paris].
Batisse A; Grégoire M; Marillier M; Fortias M; Djezzar S
Encephale; 2016 Aug; 42(4):354-60. PubMed ID: 26847479
[TBL] [Abstract][Full Text] [Related]
34. Synthetic Cannabinoids and Cathinones: Prevalence and Markets.
Bretteville-Jensen AL; Tuv SS; Bilgrei OR; Fjeld B; Bachs L
Forensic Sci Rev; 2013 Mar; 25(1-2):7-26. PubMed ID: 26226848
[TBL] [Abstract][Full Text] [Related]
35. [Synthetic drugs: the new low-cost landscape of drugs].
Karila L; Petit A; Cottencin O; Coscas S; Reynaud M
Rev Prat; 2012 May; 62(5):664-6. PubMed ID: 22730798
[TBL] [Abstract][Full Text] [Related]
36. Focus on cannabinoids and synthetic cannabinoids.
Le Boisselier R; Alexandre J; Lelong-Boulouard V; Debruyne D
Clin Pharmacol Ther; 2017 Feb; 101(2):220-229. PubMed ID: 27861784
[TBL] [Abstract][Full Text] [Related]
37. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
Every-Palmer S
Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
[TBL] [Abstract][Full Text] [Related]
38. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.
Tung CK; Chiang TP; Lam M
East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803
[TBL] [Abstract][Full Text] [Related]
39. [Effect and occurrence of synthetic cannabinoids].
Tuv SS; Strand MC; Karinen R; Øiestad EL; Christophersen AS; Vindenes V
Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2285-8. PubMed ID: 23736196
[TBL] [Abstract][Full Text] [Related]
40. Bath salts and other emerging toxins.
Thornton MD; Baum CR
Pediatr Emerg Care; 2014 Jan; 30(1):47-52; quiz 53-5. PubMed ID: 24378862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
